Skip to main content
Erschienen in: Journal of Genetic Counseling 1/2007

01.02.2007 | Original Research

Bayesian Risk Assessment in Genetic Testing for Autosomal Dominant Disorders with Age-Dependent Penetrance

verfasst von: Shuji Ogino, Robert B. Wilson, Bert Gold, Pamela Flodman

Erschienen in: Journal of Genetic Counseling | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Risk assessment is an essential component of genetic counseling and testing, and the accuracy of risk assessment is critical for decision making by consultands. However, it has been shown that genetic risk calculations may have high error rates in practice. Risk calculations for autosomal dominant disorders are frequently complicated by age-dependent penetrance and sensitivities of less than 100% in genetic testing. We provide methods of risk calculation for prototypical pedigrees of a family at risk for an autosomal dominant disorder with age-dependent penetrance. Our risk calculations include scenarios in which the sensitivity of genetic testing is less than 100%, and in which the sensitivity of genetic testing varies for different family members at risk. Our Bayesian methods permit autosomal dominant disease probabilities to be calculated accurately, taking into account all relevant information. Our methods are particularly useful for hereditary cancer syndromes, in which genetic testing can seldom achieve 100% sensitivity. Our methods can be applied to many different scenarios, including those where the sensitivity of genetic testing varies for different family members at risk.
Literatur
Zurück zum Zitat Biesecker, L. (2005). Accuracy and precision in Bayesian analysis. Am J Med Genet A, 134, 111.CrossRef Biesecker, L. (2005). Accuracy and precision in Bayesian analysis. Am J Med Genet A, 134, 111.CrossRef
Zurück zum Zitat Bonke, B., Tibben, A., Lindhout, D., Clarke, A. J., & Stijnen, T. (2005). Genetic risk estimation by healthcare professionals. Med J Aust, 182, 116–118.PubMed Bonke, B., Tibben, A., Lindhout, D., Clarke, A. J., & Stijnen, T. (2005). Genetic risk estimation by healthcare professionals. Med J Aust, 182, 116118.PubMed
Zurück zum Zitat Bonke, B., Tibben, A., Lindhout, D., & Stijnen, T. (2002). Favourable mutation test outcomes for individuals at risk for Huntington disease change the perspectives of first-degree relatives. Hum Genet, 111, 297–298.CrossRef Bonke, B., Tibben, A., Lindhout, D., & Stijnen, T. (2002). Favourable mutation test outcomes for individuals at risk for Huntington disease change the perspectives of first-degree relatives. Hum Genet, 111, 297298.CrossRef
Zurück zum Zitat Bonke, B., Tibben, A., Lindhout, D., & Stijnen, T. (2006). Calculating risk changes after negative mutation test outcomes for autosomal dominant hereditary late-onset disorders. Heredity, 96, 259–261.CrossRef Bonke, B., Tibben, A., Lindhout, D., & Stijnen, T. (2006). Calculating risk changes after negative mutation test outcomes for autosomal dominant hereditary late-onset disorders. Heredity, 96, 259261.CrossRef
Zurück zum Zitat Bridge, P. J. (1997). The Calculation of Genetic Risks: Worked Examples in DNA Diagnostics. Second Edition edn. The Johns Hopkins University Press, Baltimore. Bridge, P. J. (1997). The Calculation of Genetic Risks: Worked Examples in DNA Diagnostics. Second Edition edn. The Johns Hopkins University Press, Baltimore.
Zurück zum Zitat Flodman, P., & Hodge, S. E. (2001). A genetic risk calculation surprise. Am J Med Genet, 100, 169–171.CrossRef Flodman, P., & Hodge, S. E. (2001). A genetic risk calculation surprise. Am J Med Genet, 100, 169171.CrossRef
Zurück zum Zitat Hodge, S. E. (1998). A simple, unified approach to Bayesian risk calculations. J Genet Couns, 7, 235–261.CrossRef Hodge, S. E. (1998). A simple, unified approach to Bayesian risk calculations. J Genet Couns, 7, 235261.CrossRef
Zurück zum Zitat Hodge, S. E., & Flodman, P. L. (2004). Risk calculations: still essential in the molecular age. Am J Med Genet, 129A, 215–217.CrossRef Hodge, S. E., & Flodman, P. L. (2004). Risk calculations: still essential in the molecular age. Am J Med Genet, 129A, 215–217.CrossRef
Zurück zum Zitat Ogino, S., Flodman, P., Wilson, R. B., Gold, B., & Grody, W. W. (2005). Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests. Genet Med, 7, 317–327.CrossRef Ogino, S., Flodman, P., Wilson, R. B., Gold, B., & Grody, W. W. (2005). Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests. Genet Med, 7, 317327.CrossRef
Zurück zum Zitat Ogino, S., Leonard, D. G., Rennert, H., Ewens, W. J., & Wilson, R. B. (2002). Genetic risk assessment in carrier testing for spinal muscular atrophy. Am J Med Genet, 110, 301–307.CrossRef Ogino, S., Leonard, D. G., Rennert, H., Ewens, W. J., & Wilson, R. B. (2002). Genetic risk assessment in carrier testing for spinal muscular atrophy. Am J Med Genet, 110, 301307.CrossRef
Zurück zum Zitat Ogino, S., & Wilson, R. B. (2002). Genetic testing and risk assessment for spinal muscular atrophy (SMA). Hum Genet, 111, 477–500.CrossRef Ogino, S., & Wilson, R. B. (2002). Genetic testing and risk assessment for spinal muscular atrophy (SMA). Hum Genet, 111, 477500.CrossRef
Zurück zum Zitat Ogino, S., & Wilson, R. B. (2004). Bayesian Analysis and Risk Assessment in Genetic Counseling and Testing. J Mol Diagn, 6, 1–9.CrossRef Ogino, S., & Wilson, R. B. (2004). Bayesian Analysis and Risk Assessment in Genetic Counseling and Testing. J Mol Diagn, 6, 19.CrossRef
Zurück zum Zitat Ogino, S., Wilson, R. B., Gold, B., Hawley, P., & Grody, W. W. (2004a). Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening. Genet Med, 6, 439–449.CrossRef Ogino, S., Wilson, R. B., Gold, B., Hawley, P., & Grody, W. W. (2004a). Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening. Genet Med, 6, 439449.CrossRef
Zurück zum Zitat Ogino, S., Wilson, R. B., & Grody, W. W. (2004b). Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation. J Med Genet, 41, e70.CrossRef Ogino, S., Wilson, R. B., & Grody, W. W. (2004b). Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation. J Med Genet, 41, e70.CrossRef
Zurück zum Zitat Otto, P. A., & Maestrelli, S. R. (2000). Heterozygosity probabilities for normal relatives of isolated cases affected by incompletely penetrant conditions and the calculation of recurrence risks for their offspring. I. Autosomal dominant genes. Am J Med Genet, 95, 43–48.CrossRef Otto, P. A., & Maestrelli, S. R. (2000). Heterozygosity probabilities for normal relatives of isolated cases affected by incompletely penetrant conditions and the calculation of recurrence risks for their offspring. I. Autosomal dominant genes. Am J Med Genet, 95, 4348.CrossRef
Zurück zum Zitat Young, I. D. (1999). Introduction to risk calculation in genetic counseling. 2nd edn. Oxford University Press, Oxford. Young, I. D. (1999). Introduction to risk calculation in genetic counseling. 2nd edn. Oxford University Press, Oxford.
Metadaten
Titel
Bayesian Risk Assessment in Genetic Testing for Autosomal Dominant Disorders with Age-Dependent Penetrance
verfasst von
Shuji Ogino
Robert B. Wilson
Bert Gold
Pamela Flodman
Publikationsdatum
01.02.2007
Erschienen in
Journal of Genetic Counseling / Ausgabe 1/2007
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-006-9040-9

Weitere Artikel der Ausgabe 1/2007

Journal of Genetic Counseling 1/2007 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.